Amgen buying Turkish pharma

Amgen Inc. (NASDAQ:AMGN) said it will acquire 95.6% of Mustafa Nevzat Pharmaceuticals A.S. (Istanbul, Turkey) in a cash deal that values the Turkish pharma at $700 million. Mustafa Nevzat, which recor...